NCT04404426View on ClinicalTrials.gov

CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 4, 2020

Primary Completion Date

March 25, 2021

Study Completion Date

May 28, 2021

Conditions
ARDS Secondary to COVID-19 Pneumonia
Interventions
DIETARY_SUPPLEMENT

L-citrulline

Administration of citrulline enterally for 7 days.

OTHER

Placebo

Administration of placebo (water) enterally for 7 days

Trial Locations (1)

35000

Rennes University Hospital, Rennes

All Listed Sponsors
lead

Rennes University Hospital

OTHER

NCT04404426 - CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome | Biotech Hunter | Biotech Hunter